Home / Inspections / 1056334

FDA Inspection 1056334 — Skye Biologics Holdings LLC

Skye Biologics Holdings LLC — FEI 3005340932

The FDA completed an inspection of Skye Biologics Holdings LLC on June 11, 2018 in El Segundo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 11, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
El Segundo, CA (United States)

Facility

Other inspections at this facility

  • 1106268 (NAI Wed Sep 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 989083 (NAI Thu Aug 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 920639 (NAI Mon Feb 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 772820 (NAI Mon Feb 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 645189 (NAI Thu Feb 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources